Gráinne Donnellan

6PUBLICATIONS
86CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|Jun 20, 2025
ERBB2/HER2 Alterations in ctDNA and Metachronous Tissues of Patients with Metastatic Urothelial Cancer.

Gillian Vandekerkhove, Andrew J Murtha, David C Müller

|May 27, 2025
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.

Edmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer

|Dec 09, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Joonatan Sipola, Aslı D Munzur, Edmond M Kwan

|Mar 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.

Sofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi

Pageof 1

Frequent Collaborators

6 joint publications

Alexander W Wyatt

5 joint publications

Cameron Herberts

4 joint publications

Edmond M Kwan

3 joint publications

Sofie H Tolmeijer